What's Hot

View all perspectives
      FDG-PET uptake at baseline in GCA predicts future risk of future thoracic aneurysm

      In print here: https://t.co/2SQm18y6

      David Liew drdavidliew

      1 year ago
      FDG-PET uptake at baseline in GCA predicts future risk of future thoracic aneurysm In print here: https://t.co/2SQm18y6zP Could this help stratify aneurysmal screening? #ACR23 ABST1647 @RheumNow https://t.co/p1Dhkm2WTX
      It's OK to use TNFi in RA-ILD!
      VA study 1000+ pts using Target Trial Emulation framework: TNFi vs nonTNFi biologics/JA

      TheDaoIndex KDAO2011

      1 year ago
      It's OK to use TNFi in RA-ILD! VA study 1000+ pts using Target Trial Emulation framework: TNFi vs nonTNFi biologics/JAKi followed for 3 years. NO differences in respiratory hospitalizations or deaths or all cause mortality. abst#1582 #ACR23 #ACRbest @rheumnow https://t.co/aI2SmMrLPE
      Wolfgang Schmidt presenting @eular_org large vessel vasculitis imaging recommendations at #ACR23, acknowledging @ACRheum

      David Liew drdavidliew

      1 year ago
      Wolfgang Schmidt presenting @eular_org large vessel vasculitis imaging recommendations at #ACR23, acknowledging @ACRheum on the way. Great to see a master (& a new ACR Master) navigate with clarity, uniting different sides of the Atlantic. @RheumNow https://t.co/hyAcX8GSWf
      What do we see in GCA, with serial PET/CT after five years?

      In this Australian cohort:
      cranial uptake disappears
      extra-

      David Liew drdavidliew

      1 year ago
      What do we see in GCA, with serial PET/CT after five years? In this Australian cohort: cranial uptake disappears extra-cranial uptake sometimes emerges (but not for pts on DMARDs) Still understanding the trajectory of smouldering activity @tonysammel #ACR23 ABST1645 @RheumNow https://t.co/mKB3mjBuBt
      Factors predicting fatigue in RA differ by disease activity.
      Synovial lining hyperplasia and synovial lymphocytic infla

      Bella Mehta bella_mehta

      1 year ago
      Factors predicting fatigue in RA differ by disease activity. Synovial lining hyperplasia and synovial lymphocytic inflammation on histology were key factors. @rheumnow #ACR23 session 13M148 https://t.co/yPBZX2Rxft
      RA-ILD: the study that exonerates TNFi ?

      TNFi vs. other BioDMARDs/JAK do not increase risk of death or hospitalization

      Aurelie Najm

      1 year ago
      RA-ILD: the study that exonerates TNFi ? TNFi vs. other BioDMARDs/JAK do not increase risk of death or hospitalization over 1 and 3 yrs follow up. No subgroups stand out VHA cohort, 50% smokers No info on ILD patterns or disease trajectory ABST1582 @RheumNow #ACR23 https://t.co/frv16oRLqv
      Lovering et al. Synergestic effect of RA and CVD on dementia risk. 35% increased risk RA, 89% increased risk RA+CVD. Abs

      Richard Conway

      1 year ago
      Lovering et al. Synergestic effect of RA and CVD on dementia risk. 35% increased risk RA, 89% increased risk RA+CVD. Abstr#1628 #ACR23 @RheumNow https://t.co/Brj8XrG2o4
      #ClinicalPearl or #pathology pearl? Using synovial #biopsies to guide therapy in #RA #RCTs is a reality. But likely #fib

      Janet Pope

      1 year ago
      #ClinicalPearl or #pathology pearl? Using synovial #biopsies to guide therapy in #RA #RCTs is a reality. But likely #fibrotic #phenotype won’t respond and #lympho_myeloid has more RA damage. #ACR23 session 13M140 #Precision #medicine #ACRbest ⁦@ACRheum⁩ ⁦@RheumNow⁩ https://t.co/DmI9dNpu8w
      PET/CT real-world performance in GCA diagnosis, Sydney @tonysammel:

      comparable to other modalities
      can optimize for sen

      David Liew drdavidliew

      1 year ago
      PET/CT real-world performance in GCA diagnosis, Sydney @tonysammel: comparable to other modalities can optimize for sen or spec based on managing equivocal results ?some steroid confounding but definitely one of 3 complementary imaging options for GCA #ACR23 ABST1646 @RheumNow https://t.co/FvdLMvpqEU
      #ACR23 Abstr#1634 Promising therapy for two #Sjogren groups: 1 (high ESSDAI & ESSPRI) & 2 (low ESSDAI, high ESSP

      Md Yuzaiful Md Yusof

      1 year ago
      #ACR23 Abstr#1634 Promising therapy for two #Sjogren groups: 1 (high ESSDAI & ESSPRI) & 2 (low ESSDAI, high ESSPRI). Phase 2 RCT of Iscalimab (anti-CD40ab) showed more ISC-treated pts met the primary endpoint (ESSDAI and ESSPRI changes at WK24) vs PBO. Going to Phase 3 @RheumNow https://t.co/3bN3IS1zCO
      @Dr_K presenting long COVID data from FORWARD RA.
      These pts had some symtoms before COVID!- More comorbidites, depressi

      Bella Mehta bella_mehta

      1 year ago
      @Dr_K presenting long COVID data from FORWARD RA. These pts had some symtoms before COVID!- More comorbidites, depression patient reported scores, fibromyalgia but no different DMRD use. PHQ8 and wodepread paid were the most important PROMs @RheumNow #ACR23 https://t.co/JaWc4oDnaI
      Window of opportunity in PsA

      Higher time to diagnosis in
      -female
      -higher enthesitis
      -less swollen joints
      -lower CRP

      I

      Aurelie Najm

      1 year ago
      Window of opportunity in PsA Higher time to diagnosis in -female -higher enthesitis -less swollen joints -lower CRP If diag > 52 wks, over 3 yrs Less MDA, less remission Worse HAS-DI, PSAID Same Rx progression No diff between <12 wk & 12-52 wk @RheumNow #ACR23 ABST1641 https://t.co/Ek1CDFwENg
      #Precision #Medicine in RA RCTs. Treat w right drug at right time?

      Possible problems -sample variation on synovial #bx,

      Janet Pope

      1 year ago
      #Precision #Medicine in RA RCTs. Treat w right drug at right time? Possible problems -sample variation on synovial #bx, some won’t respond ex fibrotic phenotype variable drug distribution/resistance. AI is helping to separate Pts #ACR23 ⁦@ACRheum⁩ ⁦@RheumNow⁩ 13M140 https://t.co/D7NxpM4YNw
      Michaud et al. RA patients with long COVID had more fibromyalgia pre-COVID (41% vs 13%), higher rates of pain, depressio

      Richard Conway

      1 year ago
      Michaud et al. RA patients with long COVID had more fibromyalgia pre-COVID (41% vs 13%), higher rates of pain, depression, and worse PROs pre-COVID. Authors suggest long COVID may partially reflect pre-existing illness Abstr#1629 #ACR23 #ACRbest @RheumNow https://t.co/mrcGWrSD6c https://t.co/YiGCbvBDtn
      Haberman et al. In PsA non-white patients have higher tender (but not swollen) joint counts, higher radiographic axial d

      Richard Conway

      1 year ago
      Haberman et al. In PsA non-white patients have higher tender (but not swollen) joint counts, higher radiographic axial disease, worse skin disease. Women have higher RAPID-3 scores. Abstr#1639 #ACR23 @RheumNow https://t.co/4SL7FLzNuE https://t.co/sVwk1VaSLS

      Podcasts

      • ACR24 SpA Topic Panel Key Discussions on Spondyloarthritis
      • ACR24 - RHEUMATOID ARTHRITIS
      • ACR24 - IL - 17

      Catch up on Conference Podcasts

      Key Conference Topics

      Additional Topics

      Filter by Type

      Featured Video

      Do you get our email newsletter?

      Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

      Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

      Copyright {{ 'now'|date('Y') }} All Rights Reserved.